Literature DB >> 20136829

The role of adenosine receptors in regulating production of tumour necrosis factor-alpha and chemokines by human lung macrophages.

A Buenestado1, S Grassin Delyle, I Arnould, F Besnard, E Naline, S Blouquit-Laye, A Chapelier, J F Bellamy, P Devillier.   

Abstract

BACKGROUND AND
PURPOSE: Adenosine is a major endogenous regulator of macrophage function, and activates four specific adenosine receptors (A(1), A(2A), A(2B) and A(3)). Here, we have assessed in human lung macrophages the modulation of the expression of adenosine receptor mRNA by lipopolysaccharide (LPS), and the relative contributions of the different adenosine receptors to LPS-induced production of tumour necrosis factor (TNF)-alpha and chemokines. EXPERIMENTAL APPROACH: Lung macrophages isolated from resected lungs were stimulated with LPS and treated with adenosine receptor agonists or/and antagonists. Adenosine receptor expression was assessed with qRT-PCR. Cytokines were measured in lung macrophage supernatants with elisa. KEY
RESULTS: LPS increased (about 400-fold) mRNA for A(2A) adenosine receptors, decreased mRNA for A(1) and A(2B), but had no effect on A(3) adenosine receptor mRNA. The adenosine receptor agonist NECA inhibited TNF-alpha production concentration dependently, whereas the A(1) receptor agonist, CCPA, and the A(3) receptor agonist, AB-MECA, inhibited TNF-alpha production only at concentrations affecting A(2A) receptors. NECA also inhibited the production of CCL chemokines (CCL2, CCL3, CCL4, CCL5) and CXCL chemokines (CXCL9 and CXCL10), but not that of CXCL1, CXCL8 and CXCL5. Reversal of NECA-induced inhibition of TNF-alpha and chemokine production by the selective A(2A) adenosine receptor antagonist ZM 241385, but not the A(2B) receptor antagonist, MRS 1754, or the A(3) receptor antagonist, MRS 1220, indicated involvement of A(2A) receptors. CONCLUSIONS AND IMPLICATIONS: LPS up-regulated A(2A) adenosine receptor gene transcription, and this receptor subtype mediated inhibition of the LPS-induced production of TNF-alpha and of a subset of chemokines in human lung macrophages.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20136829      PMCID: PMC2848934          DOI: 10.1111/j.1476-5381.2009.00614.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Toll-IL-1 receptor domain-containing adaptor protein is critical for early lung immune responses against Escherichia coli lipopolysaccharide and viable Escherichia coli.

Authors:  Samithamby Jeyaseelan; Rizwan Manzer; Scott K Young; Masahiro Yamamoto; Shizuo Akira; Robert J Mason; G Scott Worthen
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

3.  beta(2)-adrenoceptor agonists inhibit release of eosinophil-activating cytokines from human airway smooth muscle cells.

Authors:  M P Hallsworth; C H Twort; T H Lee; S J Hirst
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

4.  Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE.

Authors:  T Suzuki; S Hashimoto; N Toyoda; S Nagai; N Yamazaki; H Y Dong; J Sakai; T Yamashita; T Nukiwa; K Matsushima
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

5.  Inhibition of endotoxin-induced macrophage chemokine production by VIP and PACAP in vitro and in vivo.

Authors:  M Delgado; D Ganea
Journal:  Arch Physiol Biochem       Date:  2001-10       Impact factor: 4.076

Review 6.  Adenosine receptors and asthma in humans.

Authors:  C N Wilson
Journal:  Br J Pharmacol       Date:  2008-10       Impact factor: 8.739

Review 7.  The cytokine network in asthma and chronic obstructive pulmonary disease.

Authors:  Peter J Barnes
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

8.  Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit LPS-stimulated MIP-1alpha production and mRNA expression.

Authors:  David Pozo; Juan M Guerrero; Juan R Calvo
Journal:  Cytokine       Date:  2002-04-07       Impact factor: 3.861

9.  Adenosine suppresses lipopolysaccharide-induced tumor necrosis factor-alpha production by murine macrophages through a protein kinase A- and exchange protein activated by cAMP-independent signaling pathway.

Authors:  Laura M Kreckler; Elizabeth Gizewski; Tina C Wan; John A Auchampach
Journal:  J Pharmacol Exp Ther       Date:  2009-09-11       Impact factor: 4.030

Review 10.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

Authors:  B B Fredholm; A P IJzerman; K A Jacobson; K N Klotz; J Linden
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 18.923

View more
  17 in total

1.  15-Lipoxygenases regulate the production of chemokines in human lung macrophages.

Authors:  C Abrial; S Grassin-Delyle; H Salvator; M Brollo; E Naline; P Devillier
Journal:  Br J Pharmacol       Date:  2015-07-14       Impact factor: 8.739

Review 2.  Regulation of macrophage function by adenosine.

Authors:  György Haskó; Pál Pacher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04       Impact factor: 8.311

3.  Adenosine modulates Toll-like receptor function: basic mechanisms and translational opportunities.

Authors:  Melanie R Power Coombs; Mirjam E Belderbos; Leighanne C Gallington; Louis Bont; Ofer Levy
Journal:  Expert Rev Anti Infect Ther       Date:  2011-02       Impact factor: 5.091

4.  Ankylosing spondylitis monocyte-derived macrophages express increased level of A2A adenosine receptor and decreased level of ectonucleoside triphosphate diphosphohydrolase-1 (CD39), A1 and A2B adenosine receptors.

Authors:  Maryam Akhtari; Seyed Jalal Zargar; Mahdi Mahmoudi; Mahdi Vojdanian; Alireza Rezaeimanesh; Ahmadreza Jamshidi
Journal:  Clin Rheumatol       Date:  2018-03-09       Impact factor: 2.980

5.  The Role of Toll-Like Receptors in the Production of Cytokines by Human Lung Macrophages.

Authors:  Stanislas Grassin-Delyle; Charlotte Abrial; Hélène Salvator; Marion Brollo; Emmanuel Naline; Philippe Devillier
Journal:  J Innate Immun       Date:  2018-12-17       Impact factor: 7.349

6.  Roflumilast inhibits the release of chemokines and TNF-α from human lung macrophages stimulated with lipopolysaccharide.

Authors:  A Buenestado; S Grassin-Delyle; F Guitard; E Naline; C Faisy; D Israël-Biet; E Sage; J F Bellamy; H Tenor; P Devillier
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

7.  Adenosine augments IL-10-induced STAT3 signaling in M2c macrophages.

Authors:  Balázs Koscsó; Balázs Csóka; Endre Kókai; Zoltán H Németh; Pál Pacher; László Virág; S Joseph Leibovich; György Haskó
Journal:  J Leukoc Biol       Date:  2013-08-06       Impact factor: 4.962

Review 8.  Role of adenosine A(2B) receptors in inflammation.

Authors:  Igor Feoktistov; Italo Biaggioni
Journal:  Adv Pharmacol       Date:  2011

9.  Expression and function of human hemokinin-1 in human and guinea pig airways.

Authors:  Stanislas Grassin-Delyle; Emmanuel Naline; Amparo Buenestado; Paul-André Risse; Edouard Sage; Charles Advenier; Philippe Devillier
Journal:  Respir Res       Date:  2010-10-07

10.  Roflumilast inhibits lipopolysaccharide-induced tumor necrosis factor-α and chemokine production by human lung parenchyma.

Authors:  Amparo Buenestado; Marie-Camille Chaumais; Stanislas Grassin-Delyle; Paul-André Risse; Emmanuel Naline; Elisabeth Longchampt; Hermann Tenor; Philippe Devillier
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.